Alterity Therapeutics Limited (ATHE) Stock Price

3.08 ▲ +0.02 (+0.65%)
Open: 3.05 Vol: 27.54K Day's range: 3.04 - 3.24 Dec 31, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ATHE Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 3.13▲ 3.09▲ 3.09▲ 3.09▼ 3.21▼
MA10 3.10▲ 3.10▲ 3.10▲ 3.07▲ 3.47▼
MA20 3.09▲ 3.10▲ 3.10▲ 3.19▼ 4.05▼
MA50 3.21▼ 3.27▼ 3.38▼ 3.63▼ 4.15▼
MA100 3.78▼ 4.00▼ 4.03▼ 4.18▼ 3.00▲
MA200 4.23▼ 4.32▼ 4.45▼ 4.17▼ 3.52▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.022▲ 0.025▲ 0.031▲ 0.023▲ -0.155▼
RSI 50.016▲ 46.986▼ 45.014▼ 41.318▼ 39.647▼
STOCH 68.866     65.208     61.240     61.355     15.656▼
WILL %R -40.000     -40.000     -40.000     -46.835     -83.267▼
CCI 116.053▲ 252.747▲ 188.734▲ -3.238     -91.865    
Latest Filters Detected On ATHE
MA $ATHE Price Crossed Below MA(13) Set Alert
MA $ATHE Price Crossed Below MA(7) Set Alert
Alterity Therapeutics Limited News
Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting
Thursday, April 10, 2025 04:35 AM
MELBOURNE, Australia and SAN FRANCISCO, April 10, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing ...
Maxim Group Initiates Coverage of Alterity Therapeutics Limited - Depositary Receipt () (ATHE) with Buy Recommendation
Thursday, December 12, 2024 04:05 PM
Fintel reports that on December 12, 2024, Maxim Group initiated coverage of Alterity Therapeutics Limited - Depositary Receipt () (NasdaqCM:ATHE) with a Buy recommendation. There are 13 funds or ...
Alterity Therapeutics Announces Presentation on Tracking the Progression of Multiple System Atrophy at International Symposium
Tuesday, November 12, 2024 04:34 AM
MELBOURNE, Australia and SAN FRANCISCO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing ...
ATHE historical stock data
date open high low close volume
31/12/25 3.05 3.24 3.04 3.08 27,539
30/12/25 3.00 3.24 2.97 3.06 44,760
29/12/25 3.133 3.33 2.95 3.02 17,350
26/12/25 3.05 3.29 2.9001 3.17 14,131
24/12/25 3.1216 3.31 3.05 3.095 12,173
23/12/25 3.13 3.13 3.0128 3.09 7,745
22/12/25 3.135 3.25 3.07 3.15 15,934
19/12/25 3.04 3.12 3.03 3.09 5,924
18/12/25 2.94 3.1016 2.66 3.03 13,943
17/12/25 3.03 3.14 2.92 2.92 10,610
Quote Details
52wk Low:2.521
52wk High:7.00
Vol:27.54K
Avg Vol(3m):1.9M
1Y Chng:-8.33%
1M Chng:-14.44%
Add to Watch List
More Information
Index US Composite
Market Cap. 55.83M